Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
LEICA BIOSYSTEMS NUSSLOCH GMBH Heidelberger Str. 17-19 Nussloch Germany

LEICA BIOSYSTEMS NUSSLOCH GMBH Heidelberger Str. 17-19 Nussloch Germany Recalls

All product recalls associated with LEICA BIOSYSTEMS NUSSLOCH GMBH Heidelberger Str. 17-19 Nussloch Germany.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

426

Class I (Serious)

Most Recent

Jan 2026

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 621–640 of 4598 recalls

Leica HistoCore PEGASUS Processor (Leica) – reagent level issue (2024)

Poorly processed and/or damaged biopsy tissue specimens on the device resulting from reagent levels exceeding the maximum fill level marks on reagent bottles or in the paraffin tanks.

FDAApr 10, 2024Nationwide• LEICA BIOSYSTEMS NUSSLOCH GMBH Heidelberger Str. 17-19 Nussloch Germany

CRITIKON ONE-CUF Blood Pressure Cuffs (GE Healthcare) – Inaccurate Measurements (2024)

Use of the blood pressure cuffs could result in inaccurate non-invasive blood pressure measurements.

FDAApr 9, 2024Nationwide• GE Medical Systems Information Technologies Inc

Twin Tube Sample Line (Vyaire) – Nozzle Separation Risk (2024)

Potential of the nozzle separating during patient use.

FDA

1...30 313233 34...230

Page 32 of 230Next

Apr 8, 2024

Nationwide

• Vyaire Medical, Inc. Leibnizstr. 7 Hochberg Germany

ZirCAD Ceramic Block (Ivoclar) – Sintering Crack Risk (2024)

Defective blocks may show cracks after sintering If cracks are unnoticed, restorations may fracture in the patient's mouth and require restoration

FDAApr 5, 2024Nationwide• IVOCLAR VIVADENT AG BEDERSRASSE LIECHTSTEIN Germany

CARESCAPE Canvas Smart Display (GE Healthcare) – Monitoring Loss Risk (2024)

GE HealthCare has become aware of the potential for loss of monitoring on CARESCAPE Canvas 1000, CARESCAPE Canvas Smart Display, and certain versions of CARESCAPE B850 and CARESCAPE B650 monitors if, following the replacement of the CPU timekeeper battery, a mains power loss occurs during active monitoring. In the unlikely event that this occurs, it can result in the displays or monitors not turning on, after the mains power is restored. This can result in a delay in recognizing changes in patient condition until a replacement monitor is connected.

FDAApr 5, 2024Nationwide• GE Healthcare Finland Oy Kuortaneenkatu 2 Helsinki Finland

Urinalysis Test Strips (Macherey Nagel) – Missing Test Pad (2024)

The reason for the recall is one of the test pads, for the parameter leukocytes, was missing on some of the test strips. The issue was identified by a consumer by way of a Henry Schein Inc. (HSI) customer complaint. This problem can potentially result in the possibility that the parameter leucocytes (a non-specific marker for urinary track infections and an indicator for inflammatory renal processes) is interpreted instrumentally as a false negative. The following HSI item number and lot number were affected: Urispec 11-Way, #102-2285, LOT 65402.

FDAApr 4, 2024Nationwide• Macherey Nagel Gmbh & Co. Kg Valencienner Str. 11 Duren Germany

Scopis ENT Software (Stryker) – Visual Feedback Misalignment (2024)

Unreleased software was installed on customer systems resulting in the visual feedback on the screen to show the points to be off from the physical reference point of the pointer or suction.

FDAApr 4, 2024Nationwide• Stryker Leibinger GmbH & Co. KG Botzinger Str. 41 Freiburg Im Breisgau Germany

Cyclophosphamide 1g Injection (X-Gen) – Labeling Error (2024)

Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

Class IIILow

FDAApr 2, 2024Nationwide• X-Gen Pharmaceuticals Inc.